|
Dr. Stiller is Professor Emeritus of the University of Western Ontario in the Departments of Medicine and Microbiology and Immunology. Dr. Stiller established the Multi-Organ Transplant Service in London Ontario and served as the unit’s chief from 1984 to 1996. During this period he was principal investigator of the Canadian multi-centre study that established the importance of cyclosporine in transplantation and led to its worldwide use as first-line therapy for transplant rejection. Dr. Stiller is the co-founder of two healthcare funds including the Canadian Medical Discoveries Fund Inc. where he served as Chairman and Chief Executive Officer. He was a Member of the Council and Executive Committee of the Medical Research Council of Canada (1987-1993) is currently the Chair of the Ontario Research and Development Challenge Fund and a Board Member of the Ontario Innovation Trust. Dr. Stiller serves on the Board of Directors of NPS Pharmaceuticals Inc. Residence Retirement REIT CPL Trust NeuroMedix Inc. and several Public endeavors and foundations including Chair of Genome Canada Director of MARS Discovery District) and OCRN (Ontario Cancer Research Network). He is also the recipient of numerous awards including the MEDEC Award (1992) the Order of Canada (1995) and the Order of Ontario (2000). In May 2002 Dr. Stiller received an Honourary Doctor of Laws Degree from McMaster University in Hamilton. Dr. Stiller joined Vasogen’s Board in 2006. | 